Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer
Alaa Bawaneh, Adam S. Wilson, Nicole Levi, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4849-4849
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!
Deeptashree Nandi, Sheetal Parida, Dipali Sharma
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 34
Akkermansia muciniphila: A potential target and pending issues for oncotherapy
Xu Zhao, Juanjuan Zhao, Dongmei Li, et al.
Pharmacological Research (2023) Vol. 196, pp. 106916-106916
Open Access | Times Cited: 19
Fusobacterium nucleatum: a novel immune modulator in breast cancer?
Alexa Little, Mark Tangney, Michael M. Tunney, et al.
Expert Reviews in Molecular Medicine (2023) Vol. 25
Open Access | Times Cited: 18
The microbiome: a link between obesity and breast cancer risk
Mohamed Gaber, Alana A. Arnone, Pierre‐Alexandre Vidi, et al.
Frontiers in Microbiomes (2024) Vol. 3
Open Access | Times Cited: 6
Diet Modulates the Gut Microbiome, Metabolism, and Mammary Gland Inflammation to Influence Breast Cancer Risk
Alana A. Arnone, Adam S. Wilson, David R. Soto-Pantoja, et al.
Cancer Prevention Research (2024) Vol. 17, Iss. 9, pp. 415-428
Open Access | Times Cited: 5
Unveiling the Interplay Between the Human Microbiome and Gastric Cancer: A Review of the Complex Relationships and Therapeutic Avenues
Jenan Al‐Matouq, Hawra Al-Ghafli, Noura N. Alibrahim, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 226-226
Open Access
Gut microbiota interact with breast cancer therapeutics to modulate efficacy
Alana A. Arnone, Katherine Ansley, Arielle L. Heeke, et al.
EMBO Molecular Medicine (2025)
Open Access
Indole‐3‐Lactic Acid Inhibits Doxorubicin‐Induced Ferroptosis Through Activating Aryl Hydrocarbon Receptor/Nrf2 Signalling Pathway
Jiangfang Lian, Hangyuan Guo, Zuoquan Zhong, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
Exploring the Impact of Chemotherapy on the Emergence of Antibiotic Resistance in the Gut Microbiota of Colorectal Cancer Patients
Mutebi John Kenneth, Chin‐Chia Wu, Chuan‐Yin Fang, et al.
Antibiotics (2025) Vol. 14, Iss. 3, pp. 264-264
Open Access
Predictors of Immunotherapy Response in Triple Negative Breast Cancer
Yiduo Hu, Rachel Yoder, Priyanka Sharma
Current Breast Cancer Reports (2025) Vol. 17, Iss. 1
Closed Access
The role of gut microbiota and metabolites in cancer chemotherapy
Shiyu Li, Shuangli Zhu, Jun Yu
Journal of Advanced Research (2023) Vol. 64, pp. 223-235
Open Access | Times Cited: 12
Bones and guts – Why the microbiome matters
Kelly F. Contino, Katherine L. Cook, Yusuke Shiozawa
Journal of bone oncology (2024) Vol. 44, pp. 100523-100523
Open Access | Times Cited: 4
The Interplay between Microbiota and Chemotherapy-Derived Metabolites in Breast Cancer
Julio Plaza‐Díaz, Ana I. Álvarez‐Mercado
Metabolites (2023) Vol. 13, Iss. 6, pp. 703-703
Open Access | Times Cited: 10
Breast cancer but not the menopausal status is associated with small changes of the gut microbiota
Natalia Żeber‐Lubecka, Maria Kulecka, Agnieszka Jagiełło-Gruszfeld, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Gut microbiome influences incidence and outcomes of breast cancer by regulating levels and activity of steroid hormones in women
Shilpa S. Chapadgaonkar, Srashti Bajpai, Mukul Godbole
Cancer Reports (2023) Vol. 6, Iss. 11
Open Access | Times Cited: 9
Microbiome: Mammalian milk microbiomes: sources of diversity, potential functions, and future research directions
Michael L. Power, Carly R. Muletz‐Wolz, Sally L. Bornbusch
Reproduction and Fertility (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 2
Quantification of 10 B vitamins in mouse colon by LC-MS/MS: Application on breast cancer mice treated with doxorubicin
Jing Wu, Yan Xu, Jiahong Yang, et al.
Journal of Chromatography B (2023) Vol. 1222, pp. 123714-123714
Closed Access | Times Cited: 7
NIR diagnostic imaging of triple-negative breast cancer and its lymph node metastasis for high-efficiency hypoxia-activated multimodal therapy
Yi Pan, Longcai Liu, Yichen He, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Fecal microbiome transfer an investigative tool and treatment strategy in cancer
Margaret S. Bohm, A. Ramesh, Joseph F. Pierre, et al.
AJP Gastrointestinal and Liver Physiology (2024) Vol. 327, Iss. 5, pp. G711-G726
Closed Access | Times Cited: 1
Elucidating the roles of the mammary and gut microbiomes in breast cancer development
Courtney Hoskinson, R Jiang, Leah T. Stiemsma
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Current and future research on the association between gut microbiota and breast cancer
Kuan Liu, Nan Jia, Hongyun Shi, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 3
Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs – is it a new perspective for personalized treatment of cancer patients?
Karolina Kaźmierczak-Siedlecka, Nikola Bulman, Paweł Ulasiński, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 3
The Microbiome: A New Frontier in Overcoming Drug Resistance in Breast Cancer
Thifhelimbilu Emmanuel Luvhengo, Thabiso Victor Miya, Afra Basera, et al.
(2024), pp. 261-285
Closed Access
The Role of the Gut Microbiome in Neuroinflammation and Chemotherapy-Induced Peripheral Neuropathy
Svetlana Shatunova, Rubina Aktar, Madusha Peiris, et al.
European Journal of Pharmacology (2024) Vol. 979, pp. 176818-176818
Open Access
Prognostic risk model under the immune-associated long chain non-coding ribonucleic acid and its application in survival prognosis assessment of patients with breast cancer
Shuo Yang, Qing Wang
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top